Previous reports have found that GADD45α is downregulated in HCV-positive cirrhotic HCC patients (Gramantieri et al., 2005), but direct evidence linking a loss or gain of GADD45α function in HCV-mediated liver diseases is lacking. The gene discussed is GADD45A; the disease is hepatocellular carcinoma.